Basic info
Industry
biotechnology research
Sectors
Biotechnology
Fully Human Monoclonal Antibodies
Therapeutics
Advanced Human Antibody Drug Discovery and Development
Drug Development
Biopharma
Drug Discovery
Date founded
2010
Funding rounds raised
Total raised
$100M
from 11 investors over 11 rounds
K
Kymab Ltd raised $9M on January 10, 2017
Investors: Bill & Melinda Gates Foundation
K
Kymab Ltd raised $100M on November 24, 2016
Investors: Malin Corporation plc, Wellcome Trust, Bill & Melinda Gates Foundation, Woodford Investment Management and ORI Capital Limited
K
Kymab Ltd raised $50M on May 6, 2015
Investors: Malin Corporation plc and Woodford Investment Management
K
Kymab Ltd raised $40M on May 16, 2014
Investors: Wellcome Trust and Bill & Melinda Gates Foundation
K
Kymab Ltd raised $30M on July 12, 2010
Investors: Wellcome Trust